Follow Sagimet Biosciences Inc.. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
4 Stories in coverage 0 Programs 22 recruiting Registered trials Nov 12 Latest story
Timeline 4 Pipeline 0 Trials 2
All4 Regulatory1 Trials and readouts1 Filings and people4
Details
Headquarters Foster City, CA Incorporated Delaware Industry Pharmaceutical Preparations Formerly 3-V Biosciences, Inc. (to 2019) Also known as 3-V Biosciences, Inc., SGMT How the company describes itself Sagimet develops FASN inhibitors for metabolic and fibrotic diseases driven by palmitate overproduction, including acne, MASH, and FASN-dependent tumors. The company is clinical-stage. source